These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 16553852)
21. National survey on the susceptibility of Bacteroides Fragilis Group: report and analysis of trends for 1997-2000. Snydman DR; Jacobus NV; McDermott LA; Ruthazer R; Goldstein EJ; Finegold SM; Harrell LJ; Hecht DW; Jenkins SG; Pierson C; Venezia R; Rihs J; Gorbach SL Clin Infect Dis; 2002 Sep; 35(Suppl 1):S126-34. PubMed ID: 12173121 [TBL] [Abstract][Full Text] [Related]
22. Lactobacillus acidophilus, Bifidobacterium lactis and Lactobacillus F19 prevent antibiotic-associated ecological disturbances of Bacteroides fragilis in the intestine. Sullivan A; Barkholt L; Nord CE J Antimicrob Chemother; 2003 Aug; 52(2):308-11. PubMed ID: 12865387 [TBL] [Abstract][Full Text] [Related]
23. Carbapenem resistance in Bacteroides fragilis. Ang L; Brenwald NP; Walker RM; Andrews J; Fraise A J Antimicrob Chemother; 2007 May; 59(5):1042-4. PubMed ID: 17363423 [No Abstract] [Full Text] [Related]
24. Clindamycin resistance in the Bacteroides fragilis group: association with hospital-acquired infections. Dalmau D; Cayouette M; Lamothe F; Vincelette J; Lachance N; Bourgault AM; Gaudreau C; Turgeon PL Clin Infect Dis; 1997 May; 24(5):874-7. PubMed ID: 9142785 [TBL] [Abstract][Full Text] [Related]
25. Influence of metronidazole, chloramphenicol, clindamycin and penicillin G on growth and neuraminidase activity of Bacteroides fragilis. Ferreira MC; Domingues RM; de Uzeda M J Antimicrob Chemother; 1989 Aug; 24(2):157-64. PubMed ID: 2793640 [TBL] [Abstract][Full Text] [Related]
26. Transfer of tetracycline or clindamycin resistance among strains of Bacteroides fragilis in experimental abscesses. Butler E; Joiner KA; Malamy M; Bartlett JC; Tally FP J Infect Dis; 1984 Jul; 150(1):20-4. PubMed ID: 6747344 [TBL] [Abstract][Full Text] [Related]
28. Activity of pirlimycin (U57930E) against strains of the Bacteroides fragilis group. Garcia-Rodriguez JA; Garcia-Sanchez JE; Prieto J; Sanchez de S Lorenzo A Antimicrob Agents Chemother; 1982 Nov; 22(5):893-4. PubMed ID: 7181494 [TBL] [Abstract][Full Text] [Related]
31. High rates of reduced susceptibility in the Bacteroides fragilis group isolated from blood cultures--the first national survey in Denmark. Justesen US; Hansen F; Østergaard C; Schønheyder HC; Hansen DS; Lemming LE; Schumacher H; Heltberg O; Knudsen JD; Dzajic E; Arpi M; Hammerum AM Int J Antimicrob Agents; 2013 Aug; 42(2):188-90. PubMed ID: 23773329 [No Abstract] [Full Text] [Related]
32. Use of antibiotics for prevention of Bacteroides fragilis wound sepsis in rats. Clark DG; Schweizer RT Am Surg; 1980 Mar; 46(3):180-3. PubMed ID: 7377663 [TBL] [Abstract][Full Text] [Related]
33. National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004. Snydman DR; Jacobus NV; McDermott LA; Ruthazer R; Golan Y; Goldstein EJ; Finegold SM; Harrell LJ; Hecht DW; Jenkins SG; Pierson C; Venezia R; Yu V; Rihs J; Gorbach SL Antimicrob Agents Chemother; 2007 May; 51(5):1649-55. PubMed ID: 17283189 [TBL] [Abstract][Full Text] [Related]
34. The inhibitory effect of clindamycin on Lactobacillus in vitro. Aroutcheva A; Simoes JA; Shott S; Faro S Infect Dis Obstet Gynecol; 2001; 9(4):239-44. PubMed ID: 11916182 [TBL] [Abstract][Full Text] [Related]
35. Examination of cfiA-mediated carbapenem resistance in Bacteroides fragilis strains from a European antibiotic susceptibility survey. Sóki J; Edwards R; Hedberg M; Fang H; Nagy E; Nord CE; Int J Antimicrob Agents; 2006 Dec; 28(6):497-502. PubMed ID: 17097857 [TBL] [Abstract][Full Text] [Related]
36. Resistance to tetracycline, erythromycin, and clindamycin in the Bacteroides fragilis group: inducible versus constitutive tetracycline resistance. Privitera G; Fayolle F; Sebald M Antimicrob Agents Chemother; 1981 Sep; 20(3):314-20. PubMed ID: 7305321 [TBL] [Abstract][Full Text] [Related]
37. In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group. Snydman DR; Jacobus NV; McDermott LA Antimicrob Agents Chemother; 2008 Dec; 52(12):4492-6. PubMed ID: 18838581 [TBL] [Abstract][Full Text] [Related]
38. [Influence of the inoculum effect on minimal inhibitory concentrations of 3 derivatives of 5-nitro-imidazole and 11 other antibiotics on Bacteroides fragilis]. Dusart G; Simeon de Buochberg M; Maillols H; Zuccarelli M; Attisso MA Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):685-9. PubMed ID: 3054748 [TBL] [Abstract][Full Text] [Related]
39. Sensitivity of Bacteroides fragilis to seven antimicrobial agents. Oitmaa M; Benn R Pathology; 1981 Oct; 13(4):697-703. PubMed ID: 7335376 [TBL] [Abstract][Full Text] [Related]
40. Homology between clindamycin resistance plasmids in Bacteroides. Guiney DG; Hasegawa P; Davis CE Plasmid; 1984 May; 11(3):268-71. PubMed ID: 6087395 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]